This study elucidates the effects of the intravenous (IV) lidocaine infusion on the biology
of pancreatic circulating tumor cells (CTCs) isolated from patients undergoing robotic
pancreatectomy for all types of pancreatic cancer.
A prospective randomized controlled double blinded trial design will be used for the proposed
study.